Antimullerian Hormone in Endometriomas
Anti-mullerian Hormone in Ovarian Reserve Evaluation After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery. A Pilot Study.
1 other identifier
observational
34
1 country
1
Brief Summary
The purpose of this multicenter study is to evaluate the ovarian reserve after alcohol sclerotherapy of endometriomas versus conventional surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 23, 2016
CompletedFirst Posted
Study publicly available on registry
February 1, 2016
CompletedStudy Start
First participant enrolled
February 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedFebruary 23, 2018
February 1, 2018
1.9 years
January 23, 2016
February 21, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
AMH Test
the value of AMH after both procedures in ng/mL
6 months
Secondary Outcomes (4)
antral follicles count
6 months
tumoral markers: epididimal human protein 4 (HE-4) and CA125
6 months
complications
1 day
costs
1 day
Study Arms (2)
Surgical technique
Laparoscopic ovarian cystectomy
Alcohol sclerotherapy
US-aspiration and alcohol sclerosis
Interventions
Eligibility Criteria
Patients with ultrasound suspicion of ovarian endometrioma (4-10 cm)
You may qualify if:
- Women
- Age ≥18 and \<40 years
- Unilocular endometrioma according ultrasounds
- Endometrioma size: 35-100 mm during \> 3 months from diagnosis
- CA125 \<200 IU/mL and HE4 \< 70,
- AMH previous surgery between 1.2-4 ng/mL
You may not qualify if:
- Previous ovarian surgery or gynecological cancer
- Severe extraovarian endometriosis
- Dermoid or high risk of malignancy cysts
- Hormonal treatment 3 months before
- Pregnancy
- Mental disability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital Universitari de Bellvitgelead
- Roche Diagnostic Ltd.collaborator
Study Sites (1)
Hospital Universitario Bellvitge
L'Hospitalet de Llobregat, Barcelona, 08908, Spain
Related Publications (12)
Coccia ME, Rizzello F, Cammilli F, Bracco GL, Scarselli G. Endometriosis and infertility Surgery and ART: An integrated approach for successful management. Eur J Obstet Gynecol Reprod Biol. 2008 May;138(1):54-9. doi: 10.1016/j.ejogrb.2007.11.010. Epub 2008 Feb 20.
PMID: 18243485BACKGROUNDMuzii L, Bianchi A, Croce C, Manci N, Panici PB. Laparoscopic excision of ovarian cysts: is the stripping technique a tissue-sparing procedure? Fertil Steril. 2002 Mar;77(3):609-14. doi: 10.1016/s0015-0282(01)03203-4.
PMID: 11872220BACKGROUNDRaffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012 Sep;97(9):3146-54. doi: 10.1210/jc.2012-1558. Epub 2012 Jun 20.
PMID: 22723324BACKGROUNDBiacchiardi CP, Piane LD, Camanni M, Deltetto F, Delpiano EM, Marchino GL, Gennarelli G, Revelli A. Laparoscopic stripping of endometriomas negatively affects ovarian follicular reserve even if performed by experienced surgeons. Reprod Biomed Online. 2011 Dec;23(6):740-6. doi: 10.1016/j.rbmo.2011.07.014. Epub 2011 Jul 27.
PMID: 22019621BACKGROUNDAkamatsu N, Hirai T, Masaoka H, Sekiba K, Fujita T. [Ultrasonically guided puncture of endometrial cysts--aspiration of contents and infusion of ethanol]. Nihon Sanka Fujinka Gakkai Zasshi. 1988 Feb;40(2):187-91. Japanese.
PMID: 3283269BACKGROUNDNoma J, Yoshida N. Efficacy of ethanol sclerotherapy for ovarian endometriomas. Int J Gynaecol Obstet. 2001 Jan;72(1):35-9. doi: 10.1016/s0020-7292(00)00307-6.
PMID: 11146075BACKGROUNDMessalli EM, Cobellis G, Pecori E, Pierno G, Scaffa C, Stradella L, Cobellis L. Alcohol sclerosis of endometriomas after ultrasound-guided aspiration. Minerva Ginecol. 2003 Aug;55(4):359-62.
PMID: 14581861BACKGROUNDKafali H, Eser A, Duvan CI, Keskin E, Onaran YA. Recurrence of ovarian cyst after sclerotherapy. Minerva Ginecol. 2011 Feb;63(1):19-24.
PMID: 21311417BACKGROUNDYazbeck C, Madelenat P, Ayel JP, Jacquesson L, Bontoux LM, Solal P, Hazout A. Ethanol sclerotherapy: a treatment option for ovarian endometriomas before ovarian stimulation. Reprod Biomed Online. 2009 Jul;19(1):121-5. doi: 10.1016/s1472-6483(10)60055-7.
PMID: 19573300BACKGROUNDGarcia-Tejedor A, Castellarnau M, Ponce J, Fernandez ME, Burdio F. Ethanol sclerotherapy of ovarian endometrioma: a safe and effective minimal invasive procedure. Preliminary results. Eur J Obstet Gynecol Reprod Biol. 2015 Apr;187:25-9. doi: 10.1016/j.ejogrb.2015.02.004. Epub 2015 Feb 16.
PMID: 25739052BACKGROUNDSomigliana E, Berlanda N, Benaglia L, Vigano P, Vercellini P, Fedele L. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimullerian hormone level modifications. Fertil Steril. 2012 Dec;98(6):1531-8. doi: 10.1016/j.fertnstert.2012.08.009. Epub 2012 Sep 10.
PMID: 22975114BACKGROUNDKoike T, Minakami H, Motoyama M, Ogawa S, Fujiwara H, Sato I. Reproductive performance after ultrasound-guided transvaginal ethanol sclerotherapy for ovarian endometriotic cysts. Eur J Obstet Gynecol Reprod Biol. 2002 Oct 10;105(1):39. doi: 10.1016/s0301-2115(02)00144-6.
PMID: 12270563BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amparo Garcia-Tejedor, MDPhD
Hospital de Bellvitge. IDIBELL
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
January 23, 2016
First Posted
February 1, 2016
Study Start
February 1, 2016
Primary Completion
January 1, 2018
Study Completion
January 1, 2018
Last Updated
February 23, 2018
Record last verified: 2018-02
Data Sharing
- IPD Sharing
- Will share
The individual participant data should be available 6 months after the procedure